Wray NR, Lin T, Austin J, McGrath JJ, Hickie IB, Murray GK, et al. From basic science to clinical application of polygenic risk scores: a primer. JAMA Psychiatry. 2021;78:101–9.
Fullerton JM, Nurnberger JI. Polygenic risk scores in psychiatry: Will they be useful for clinicians? F1000Research. 2019;8.
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.
Mars N, Koskela JT, Ripatti P, Kiiskinen TT, Havulinna AS, Lindbohm JV, et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med. 2020;26:549–57.
Lambert SA, Abraham G, Inouye M. Towards clinical utility of polygenic risk scores. Hum Mol Genet. 2019;28:R133–42.
Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219.
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104:21–34.
Weale ME, Riveros-Mckay F, Selzam S, Seth P, Moore R, Tarran WA, et al. Validation of an integrated risk tool, including polygenic risk score, for atherosclerotic cardiovascular disease in multiple ethnicities and ancestries. Am J Cardiol. 2021;148:157–64.
Riveros-Mckay F, Weale ME, Moore R, Selzam S, Krapohl E, Sivley RM, et al. Integrated polygenic tool substantially enhances coronary artery disease prediction. Circ Genom Precis Med. 2021;14:e003304.
Anderson JS, Shade J, DiBlasi E, Shabalin AA, Docherty AR. Polygenic risk scoring and prediction of mental health outcomes. Curr Opin Psychol. 2019;27:77–81.
Jonas K, Lencz T, Li K, Malhotra AK, Perlman G, Fochtmann LJ, et al. Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders. Transl Psychiatry. 2019;9:1–8.
Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, Euesden J, et al. An examination of polygenic score risk prediction in individuals with first-episode psychosis. Biol Psychiatry. 2017;81:470–7.
Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, et al. Schizophrenia polygenic risk score as a predictor of antipsychotic efficacy in first-episode psychosis. Am J Psychiatry. 2018;176:21–8.
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.
Smigielski L, Papiol S, Theodoridou A, Heekeren K, Gerstenberg M, Wotruba D, et al. Polygenic risk scores across the extended psychosis spectrum. Transl Psychiatry. 2021;11:1–11.
Liebers DT, Pirooznia M, Seiffudin F, Musliner KL, Zandi PP, Goes FS. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults. Schizophr Bull. 2016;42:984–91.
Lake AM, Zhou Y, Wang B, Actkins KV, Zhang Y, Shelley JP, et al. Sexual Trauma, Polygenic Scores, and Mental Health Diagnoses and Outcomes. JAMA Psychiatry. 2025;82:75–84.
Gui Y, Zhou X, Wang Z, Zhang Y, Wang Z, Zhou G, et al. Sex-specific genetic association between psychiatric disorders and cognition, behavior and brain imaging in children and adults. Transl Psychiatry. 2022;12:1–8.
Liebers DT, Pirooznia M, Ganna A. Study (BiGS) BG, Goes FS. Discriminating bipolar depression from major depressive disorder with polygenic risk scores. Psychol Med. 2021;51:1451–8.
Loughnan RJ, Palmer CE, Makowski C, Thompson WK, Barch DM, Jernigan TL, et al. Unique prediction of developmental psychopathology from genetic and familial risk. J Child Psychol Psychiatry. 2022;63:1631–43.
Mistry S, Escott-Price V, Florio AD, Smith DJ, Zammit S. Investigating associations between genetic risk for bipolar disorder and cognitive functioning in childhood. J Affect Disord. 2019;259:112–20.
Wu CS, Hsu CL, Lin MC, Su MH, Lin YF, Chen CY, et al. Association of polygenic liabilities for schizophrenia and bipolar disorder with educational attainment and cognitive aging. Transl Psychiatry. 2024;14:1–8.
Ferraro L, Quattrone D, La Barbera D, La Cascia C, Morgan C, Kirkbride JB, et al. First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data. Schizophr Bull. 2023;49:218–27.
Richards AL, Pardiñas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, et al. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia. Schizophr Bull [Internet]. [cited 2019 Jul 2]; Available from: https://academic-oup-com.proxy.library.stonybrook.edu/schizophreniabulletin/advance-article/doi/10.1093/schbul/sbz061/5519548.
Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, et al. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disord. 2019;21:68–75.
Schubert KO, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, et al. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Transl Psychiatry. 2021;11:606.
Bigdeli TB, Barr PB, Rajeevan N, Graham DP, Li Y, Meyers JL, et al. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry. 2024;29:2399–407.
Lopes FL, Zhu K, Purves KL, Song C, Ahn K, Hou L, et al. Polygenic risk for anxiety influences anxiety comorbidity and suicidal behavior in bipolar disorder. Transl Psychiatry. 2020;10:298.
Dwyer DB, Kalman JL, Budde M, Kambeitz J, Ruef A, Antonucci LA, et al. An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study. JAMA Psychiatry. 2020;77:523–33.
David FS, Stein F, Andlauer TFM, Streit F, Witt SH, Herms S, et al. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders. Schizophr Res. 2023;252:161–71.
Song J, Jonsson L, Lu Y, Bergen SE, Karlsson R, Smedler E, et al. Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder. Mol Psychiatry. 2024 Feb 14;1–10.
Rodriguez V, Alameda L, Quattrone D, Tripoli G, Gayer-Anderson C, Spinazzola E, et al. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. Psychol Med. 2022;1–10.
Kalman JL, Papiol S, Grigoroiu-Serbanescu M, Adorjan K, Anderson-Schmidt H, Brosch K, et al. Genetic risk for psychiatric illness is associated with the number of hospitalizations of bipolar disorder patients. J Affect Disord. 2022;296:532–40.
Kämpe A, Suvisaari J, Lähteenvuo M, Singh T, Ahola-Olli A, Urpa L, et al. Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders. Mol Psychiatry. 2024 Apr 1;1–9.
Day FR, Loh PR, Scott RA, Ong KK, Perry JRB. A Robust Example of Collider Bias in a Genetic Association Study. Am J Hum Genet. 2016;98:392–3.
Akimova ET, Breen R, Brazel DM, Mills MC. Gene-environment dependencies lead to collider bias in models with polygenic scores. Sci Rep. 2021;11:9457.
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022.
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:s13742–015.
Budde M, Anderson-Schmidt H, Gade K, Reich-Erkelenz D, Adorjan K, Kalman JL, et al. A longitudinal approach to biological psychiatric research: The PsyCourse study. Am J Med Genet B Neuropsychiatr Genet. 2019;180:89–102.
First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). Compr Handb Psychol Assess. 2004;2:134–43.
1000 Genomes Project Consortium. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491:56.
O’Connell J, Sharp K, Shrine N, Wain L, Hall I, Tobin M, et al. Haplotype estimation for biobank scale datasets. Nat Genet. 2016;48:817–20.
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.
Purcell S PLINK 1.9 [Internet]. Available from: http://pngu.mgh.harvard.edu/purcell/plink/.
Bromet EJ, Schwartz JE, Fennig S, Geller L, Jandorf L, Kovasznay B, et al. The epidemiology of psychosis: the Suffolk County Mental Health Project. Schizophr Bull. 1992;18:243–55.
Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9.
Andreasen NC. Scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa; 1984.
Andreasen NC. Scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa; 1984.
Liberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005;56:735–42.
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812.
Heinrichs DW, Hanlon TE, Carpenter JrWT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10:388–98.
Kotov R, Foti D, Li K, Bromet EJ, Hajcak G, Ruggero CJ. Validating dimensions of psychosis symptomatology: Neural correlates and 20-year outcomes. J Abnorm Psychol. 2016;125:1103.
Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults. Schizophr Bull. 2001;27:235–45.
Browning BL, Browning SR. Genotype Imputation with Millions of Reference Samples. Am J Hum Genet. 2016;98:116–26.
Ruderfer DM, Ripke S, McQuillin A, Boocock J, Stahl EA, Pavlides JMW, et al. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 2018;173:1705–1715.e16.
Huang QQ, Wigdor EM, Malawsky DS, Campbell P, Samocha KE, Chundru VK, et al. Examining the role of common variants in rare neurodevelopmental conditions. Nature. 2024;636:404–11.
Ripke S, Neale BM, Corvin A, Walters JT, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421.
Okhuijsen-Pfeifer C, van der Horst MZ, Bousman CA, Lin B, van Eijk KR, Ripke S, et al. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders. Transl Psychiatry. 2022;12:1–9.
Pardiñas AF, Smart SE, Willcocks IR, Holmans PA, Dennison CA, Lynham AJ, et al. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia. JAMA Psychiatry [Internet]. 2022. https://doi.org/10.1001/jamapsychiatry.2021.3799. Jan [cited 2022 Jan 27]; Available from.
Mundy J, Hübel C, Adey BN, Davies HL, Davies MR, Coleman JRI, et al. Genetic examination of the Mood Disorder Questionnaire and its relationship with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2023;192:147–60.
Grotzinger AD, Mallard TT, Akingbuwa WA, Ip HF, Adams MJ, Lewis CM, et al. Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. Nat Genet. 2022;54:548–59.
O’Connell KS, Koromina M, van der Veen T, Boltz T, David FS, Yang JMK, et al. Genomics yields biological and phenotypic insights into bipolar disorder. Nature. 2025;639:968–75.
Schoeler T, Speed D, Porcu E, Pirastu N, Pingault JB, Kutalik Z. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7:1216–27.
Ahangari M, Bustamante D, Kirkpatrick R, Nguyen TH, Verrelli BC, Fanous A, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. Br J Psychiatry. 2023;223:301–8.
Hafeman DM, Uher R, Merranko J, Zwicker A, Goldstein B, Goldstein TR, et al. Person-level contributions of bipolar polygenic risk score to the prediction of new-onset bipolar disorder in at-risk offspring. J Affect Disord. 2025;368:359–65.
Segura AG, Mezquida G, Martínez-Pinteño A, Gassó P, Rodriguez N, Moreno-Izco L, et al. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. Psychol Med. 2022;1–14.
Askeland RB, Hannigan LJ, O’Connell KS, Corfield EC, Frei O, Thapar A, et al. Developmental manifestations of polygenic risk for bipolar disorder from infancy to middle childhood. Transl Psychiatry. 2023;13:1–9.
Bigdeli TB, Voloudakis G, Barr PB, Gorman BR, Genovese G, Peterson RE, et al. Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System. JAMA Psychiatry. 2022;79:1092–101.
Cabrera-Mendoza B, Aydin N, Fries GR, Docherty AR, Walss-Bass C, Polimanti R. Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach. Neuropsychopharmacology. 2024;49:1383–91.
Hosang GM, Martin J, Karlsson R, Lundström S, Larsson H, Ronald A, et al. Association of etiological factors for hypomanic symptoms, bipolar disorder, and other severe mental illnesses. JAMA Psychiatry. 2022;79:143–50.
Mistry S, Escott-Price V, Florio AD, Smith DJ, Zammit S. Genetic risk for bipolar disorder and psychopathology from childhood to early adulthood. J Affect Disord. 2019;246:633–9.
Sanchez-Ruiz JA, Coombes BJ, Pazdernik VM, Melhuish Beaupre LM, Jenkins GD, Pendegraft RS, et al. Clinical and genetic contributions to medical comorbidity in bipolar disorder: a study using electronic health records-linked biobank data. Mol Psychiatry. 2024;1–13.